4//SEC Filing
Davis Todd C 4
Accession 0002001011-25-000013
CIK 0000886163other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:44 PM ET
Size
9.3 KB
Accession
0002001011-25-000013
Insider Transaction Report
Form 4
Davis Todd C
Director
Transactions
- Award
Common Stock
2025-02-14+20,784→ 143,794 total - Tax Payment
Common Stock
2025-02-14$120.00/sh−6,966$835,920→ 136,828 total - Tax Payment
Common Stock
2025-02-15$120.00/sh−2,231$267,720→ 134,597 total - Tax Payment
Common Stock
2025-02-15$120.00/sh−4,255$510,600→ 130,342 total
Footnotes (3)
- [F1]Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs).
- [F2]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units.
- [F3]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001392029
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:44 PM ET
- Size
- 9.3 KB